John Craig Thompson
Director · Esperion Therapeutics, Inc.
Individual
- 2025
- Jul 13, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Craig Thompson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sheldon L. Koenig - $239K in ESPR purchases and sales in the last 12 months
- Benjamin Looker - $61K in ESPR purchases and sales in the last 12 months
- Benjamin Halladay - $51K in ESPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Craig Thompson?
John Craig Thompson is a corporate insider, tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John Craig Thompson last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 3 filings going back to 2025.
